<!DOCTYPE html>
<html>
    <head>
        <meta charset="utf-8">
<meta http-equiv="X-UA-Compatible" content="IE=edge"/>
        <script src='echarts.min-4.8.0.js'></script>
        <script src='echarts-wordcloud.min.js'></script>
    </head>
    <body>
        <style>
            html, body, #main {
                width: 100%;
                height: 100%;
                margin: 0;
            }
        </style>
        <div id='main'></div>
        <script>
            var chart = echarts.init(document.getElementById('main'));
            var keywords = {"Cancer intervention":1,
"Oncology":1,
"Prevention":1,
"Stroke":1,
"Therapeutic indications":1,
"TNF-α":1,
"biomarkers":3,
"breast cancer":11,
"interleukin-6":1,
"interleukin-8":1,
"Autophagy/mitophagy":1,
"Expression profiles":1,
"Mitochondrial genomes":1,
"Nuclear genomes":1,
"Oncocytic phenotype":1,
"Thyroid carcinoma":6,
"Extraosseous Ewing sarcoma":1,
"Nerve sheath tumor":1,
"Primitive neuroectodermal tumor":1,
"Sciatic nerve":1,
"Active surveillance":2,
"Papillary thyroid microcarcinoma":4,
"Prospective cohort":1,
"Thyroid neoplasms":6,
"CT":2,
"Head/neck":1,
"dual-energy CT":1,
"image quality":1,
"radiation exposure":1,
"gene mutation":1,
"cribriform-morular variant of papillary thyroid carcinoma":1,
"inherited thyroid cancer":1,
"molecular genetic analysis":1,
"poorly differentiated papillary thyroid carcinoma":1,
"β-catenin gene mutation":1,
"Cell growth":1,
"PI3K/AKT":1,
"SPC24":1,
"Anaplastic thyroid carcinoma":5,
"CDKN2A":1,
"CDKN2B":1,
"HRAS":2,
"Palbociclib":1,
"Tipifarnib":1,
"epidemiology":1,
"incidence":1,
"medical overuse":1,
"mortality":2,
"thyroid neoplasm":2,
"Breast cancers":1,
"Cancer stem cells":2,
"Chemotherapy resistance":1,
"Tamoxifen":1,
"Vitamin D receptor":1,
"differentiated thyroid carcinoma":2,
"dosimetry":1,
"effective half-life":1,
"radioiodine therapy":1,
"recombinant human thyroid-stimulating hormone":1,
"thyroid uptake":1,
"exercise":1,
"neoplasms":2,
"obesity":2,
"potential impact fraction":1,
"risk factors":2,
"131I therapy":1,
"differentiated thyroid cancer":4,
"documentation":1,
"security checkpoint":1,
"FT-UMP":1,
"clear cell change":1,
"endocrine pathology":1,
"follicular thyroid tumor":2,
"malignancy":4,
"HOXA-AS2":1,
"HOXA3":1,
"Wnt/β-catenin signaling pathway":1,
"miR-15a-5p":1,
"papillary thyroid cancer":9,
"diagnostic accuracy":1,
"head and neck lesion":1,
"intraoperative diagnosis":1,
"liquid-based cytology of rinsed tissue fragments":1,
"Differentially expressed gene":1,
"Fusion genes":1,
"RNA-seq":2,
"Radioactive iodine therapy":1,
"Recombinant human thyrotropin":1,
"Renal function":1,
"Thyroid hormone withdrawal":1,
"Diagnostic value":1,
"Thyroid nodule":6,
"Ultrasound":5,
"fine needle aspiration cytology":1,
"head and neck":1,
"lymph node":2,
"salivary gland":1,
"thyroid gland":2,
"incidental thyroid cancer":1,
"non-incidental thyroid cancer":1,
"anaplastic thyroid cancer":1,
"combination therapy":1,
"lenvatinib":2,
"orthotopic mouse model":1,
"programmed cell death-1":1,
"Carcinoma":2,
"Core Needle Biopsy":1,
"Fine Needle Aspiration":2,
"Immunohistochemistry":6,
"lateral neck dissection":1,
"lymph node metastasis":1,
"metastasis pattern":1,
"operation extent":1,
"recurrence":5,
"tomography":1,
"ultrasonography":7,
"Benign thyroid nodule":1,
"Nature of thyroid nodule":1,
"Radiofrequency ablation":1,
"Therapeutic success":1,
"Volume reduction":1,
"cytoplasmic elongation":1,
"palisaded pattern":1,
"papillary thyroid carcinoma":7,
"soap bubble appearance":1,
"tall cell variant":1,
"tombstone appearance":1,
"hemithyroidectomy":1,
"hypothyroidism":2,
"thyroiditis":3,
"Bilateral axillo-breast approach":1,
"Parathyroid":1,
"Robotic thyroidectomy":2,
"SCASI":1,
"Subcapsular saline injection":1,
"Zenker's diverticulum":1,
"fine-needle aspiration":1,
"Choline":1,
"Incidental":1,
"PET/CT":2,
"Positron emission tomography":1,
"Thyroid":8,
"Thyroid incidentaloma":2,
"multiple endocrine neoplasias":1,
"prophylactic surgical procedures":1,
"clomiphene":1,
"infertility":2,
"population cohort":1,
"thyroid cancer":17,
"endocrine gland neoplasms":1,
"follicular variant":2,
"histologic variants":1,
"Calcitonin":4,
"Carcinoembryonic antigen":2,
"PET-CT Scan":1,
"Thyroid cancer, medullary":1,
"Guideline":1,
"Mouth Neoplasms":1,
"Republic of Korea":1,
"Squamous Cell Carcinoma":3,
"Surgery":3,
"Hyperparathyroidism":1,
"PTH":1,
"Parathyroid adenomas":1,
"Rapid washout":1,
"CD56":1,
"Follicular-variant":1,
"Galectin-3":1,
"HBME-1":1,
"Papillary carcinoma":2,
"TNM classification":1,
"outcome assessment":1,
"prognosis":7,
"thyroidectomy":2,
"tumour staging":1,
"Esophageal injury":1,
"Esophageal stenting":1,
"Tracheomalacia":1,
"Transsternal approach":1,
"Vertebral metastasis":1,
"Neuroendocrine cells":1,
"Thyroglossal duct":1,
"Thyroglossal duct cyst":1,
"18F-FDG PET/CT":1,
"EU-TIRADS":1,
"diagnosis":2,
"high-density lipoprotein cholesterol":1,
"metabolic syndrome":1,
"thyroid volume":1,
"waist circumference":1,
"(131)I":1,
"Cáncer diferenciado de tiroides":1,
"Dynamic risk stratification":1,
"Estratificación dinámica de riesgo":1,
"Estratificación inicial de riesgo":1,
"Initial risk stratification":1,
"Radioiodine treatment":1,
"Tratamiento con radioyodo":1,
"remote-access thyroidectomy":2,
"transoral thyroidectomy":2,
"Fusion imaging":1,
"Hybrid imaging":1,
"Single-photon emission computed tomography/ultrasound":1,
"JAK":1,
"NF-κB":2,
"STAT3":1,
"(68)Ga-Dotatate":1,
"Ectopic pituitary adenoma":1,
"Hyperthyroidism":2,
"TSH":1,
"Afirma":1,
"GSC":1,
"atypia":1,
"indeterminate cytology":1,
"radiology":1,
"radiology—treatment":1,
"thyroid nodules":5,
"Epithelial ovarian cancer":1,
"Follicle-stimulating hormone":1,
"Glycolysis":2,
"Pyruvate kinase isozyme type M2":1,
"TTN-AS1":1,
"ZNRF2":1,
"ceRNA":1,
"miR-153-3p":1,
"Central lymph node dissection":1,
"Hypoparathyroidism":1,
"Thymectomy":1,
"Chinese women":1,
"LC-MS/MS":1,
"Thyroid autoantibody":1,
"Urinary bisphenol A":1,
"Cytokines":2,
"Sapylin":1,
"Wound Healing":1,
"Cervical cancer":1,
"Meta-analysis":3,
"POLR2E":1,
"rs3787016":1,
"BRAF V600E":1,
"Network medicine":1,
"Prediction of response":1,
"Vemurafenib":1,
"Breg":1,
"PD-1":1,
"Thyroid tumor":1,
"Iodine Radioisotopes":1,
"Neck Dissection":2,
"Thyrotoxicosis":1,
"Argonaute proteins":1,
"Hallmark of cancer":1,
"Mononucleotide A-T repeats":1,
"Universal target":1,
"cis-Regulatory elements":1,
"assisted reproduction":1,
"cancer":4,
"female infertility":1,
"fertility treatment":1,
"calcification":1,
"tumor volume doubling time":1,
"Fine-needle aspiration cytology":1,
"Noninvasive follicular thyroid tumor with papillary-like nuclear features (NIFTP)":1,
"18F-Choline PET-CT":1,
"PET-CT":1,
"mismatch repair":1,
"angiogenesis":2,
"exosome":2,
"miRNA":1,
"Cancer incidence":1,
"Epidemiological study":1,
"Görtschitztal valley":1,
"Hexachlorobenzene":1,
"Mesothelioma":1,
"Apoptosis":4,
"Autophagy":2,
"Nuclear translocation":1,
"PKM2":2,
"Structure-activity relationships":1,
"Ovarian cancer":2,
"Survival":2,
"TSH suppression therapy":1,
"mutation":1,
"dabrafenib":1,
"radioactive iodine":1,
"redifferentiation":1,
"trametinib":1,
"C cell hyperplasia":1,
"disease model":1,
"knock-in":1,
"medullary thyroid carcinoma":4,
"reporter line":1,
"ret mutant":1,
"adenomatous polyposis coli":1,
"colorectal neoplasms":1,
"genotype":1,
"germline pathogenic variants":1,
"phenotype":1,
"Neutrophil–lymphocyte ratio":1,
"platelet–lymphocyte ratio":1,
"Central lymph node metastasis":1,
"Urinary iodine":1,
"follicular adenoma":1,
"noninvasive follicular thyroid neoplasm":1,
"3R":1,
"endocrine cancers":1,
"precilinal trials":1,
"AJCC eighth edition":1,
"extrathyroidal extension":1,
"pathology":1,
"staging":1,
"Cervical lymph nodes":1,
"Neck mass":1,
"Complication":1,
"Conservative thyroidectomy":1,
"53BP1":1,
"DNA damage response":1,
"genomic instability":1,
"immunofluorescence":2,
"thyroid follicular tumors":1,
"MMP20":1,
"SIBLING-MMP interaction":1,
"dentin sialophosphoprotein":1,
"in situ proximity ligation assay":1,
"tissue microarrays":1,
"Curcumin":1,
"Piperin":1,
"TPC-1 cells":1,
"Vitamin E":1,
"Hippo signalling pathway":1,
"TNRC6C-AS1":1,
"long noncoding RNA":1,
"proliferation":1,
"serine/threonine kinase 4":1,
"5-fluorouracil":1,
"HMGA2":1,
"chemoresistance":1,
"colorectal cancer":1,
"lncRNA prostate cancer-associated transcript 6":1,
"miR-204":1,
"tumor size":1,
"8505C cells":1,
"sodium orthovanadate":1,
"tumor growth":1,
"X-chromosome inactivation pattern":1,
"clonal analysis":1,
"human androgen receptor gene":1,
"Autonomous thyroid function":1,
"Iodine exposure":1,
"Nodular goiter":1,
"Intermediate risk":1,
"Papillary cancer":1,
"Treatment results":1,
"Immune-checkpoint inhibitor":1,
"ketoacidosis":1,
"non-small cell lung cancer":1,
"type 1 diabetes mellitus":1,
"Notch signaling":1,
"T helper 17 cells":1,
"gastric cancer":2,
"regulatory T cells":1,
"charcoal tattoo":1,
"differentiated thyroid cancer recurrence":1,
"surgical complications":1,
"Esophageal NEC":1,
"Gastroenteropancreatic NET":1,
"Large cell esophageal NEN":1,
"MANEC":1,
"Small cell carcinoma":1,
"Bcl-2":1,
"Bcl-XL":1,
"miR-1915-3p":1,
"Lysosome":1,
"Protein translation":1,
"Starvation":1,
"TFEB":1,
"mTORC1":1,
"Fine-needle biopsy":1,
"Molecular pathology":1,
"Overtreatment":1,
"Intraparotid node":1,
"Mucoepidermoid carcinoma":1,
"Parotid cancer":2,
"131I measurement":1,
"Chernobyl":1,
"External contamination":1,
"Internal contamination":1,
"HER2 status":1,
"Nomogram":1,
"Prediction and validation":1,
"HCC":1,
"JNK":1,
"ROS":1,
"SIRT1":1,
"cisplatin":1,
"miR-124":1,
"PROX1":1,
"cytoskeleton":1,
"follicular thyroid carcinoma":1,
"invasion":3,
"migration":3,
"9/11":1,
"screening":1,
"Transoral robotic thyroidectomy":1,
"25(oh)D3":1,
"Correlation analysis":1,
"Deficiency of vitamin D":1,
"Insulin-like growth factor-1":1,
"TERT promoter mutation":1,
"Targeted next generation sequencing":1,
"bone marrow":1,
"complete blood count":1,
"elderly":1,
"radiation":1,
"radioiodine":1,
"Minor":1,
"Pathology, clinical":1,
"Thyroid neosplams":1,
"Cold atmospheric plasma":1,
"calreticulin":1,
"colon cancer":1,
"high-mobility group box 1 protein":1,
"MMP-2":1,
"PFOA":1,
"follicular thyroid cancer":1,
"Mature cystic teratoma":1,
"carcinoid":1,
"MicroRNA":1,
"Poorly differentiated thyroid carcinoma":1,
"Tyrosine kinase inhibitor":1,
"NIFTP":1,
"NIFTP incidence":1,
"ROM":1,
"Thyroid Bethesda":1,
"Thyroid cytopathology":1,
"Aerobic glycolysis":1,
"Hepatocellular carcinoma":1,
"Proanthocyanidin B2":1,
"Sorafenib":1,
"Advanced thyroid carcinoma":1,
"Tyrosine kinase inhibitor (TKI)":1,
"MET/EMT":1,
"adiponectin":1,
"high-density lipoproteins":1,
"leptin":1,
"low-density lipoproteins":1,
"signaling pathways":1,
"RUNX2":1,
"epigenetic":1,
"epithelial mesenchymal transition":1,
"histone":1,
"lung cancer":1,
"Acinic cell carcinoma":1,
"Distant metastasis":1,
"High-grade transformation":1,
"Intraparotid node metastasis":1,
"COX-2":1,
"Macrophages":1,
"Oncogene-induced senescence":1,
"PGE2":1,
"Thyrocytes":1,
"IDH2":1,
"function analysis":1,
"therapeutic target":1,
"thyroid papillary carcinoma":1,
"kinase inhibitors":1,
"microvessel density":1,
"tumors":1,
"COPB2":1,
"EMT":1,
"carcinogenic biomarkers":1,
"drug data mining":1,
"genetic and epigenetic drug targets":1,
"genetic and epigenetic network":1,
"next-generation sequencing (NGS) data":1,
"positive CD133 cancer stem cells":1,
"BRAF inhibition":1,
"sodium":1,
"iodide symporter":1,
"Risk assessment":2,
"Skip metastasis":1,
"aggressiveness":2,
"metastasis":3,
"signal transduction":1,
"spheroids":1,
"target":1,
"three-dimensional growth":1,
"head and neck cancer":1,
"laryngeal cancer":1,
"laryngeal neoplasm":1,
"laryngo-esophageal disfunction":1,
"multidisciplinary team":1,
"Artificial neural network":1,
"Variant pathway":1,
"Adipocytes":1,
"Exosomes":1,
"Tumour progression":1,
"JNK-MIEF1 pathway":1,
"MDA-T32 cells":1,
"Mitochondrial fission":1,
"C-index":1,
"cancer staging":1,
"dendrogram":1,
"machine learning":1,
"drug discovery screening":1,
"estrogen receptor":1,
"nuclear receptors":1,
"primary cells":1,
"Hashimoto’s thyroiditis":1,
"Calcitonin negative":1,
"Chromogranin a":1,
"Procalcitonin":1,
"Endocrine surgery":1,
"Hypercalcemia":1,
"Hyperparparathyroidism":1,
"MEN 1":1,
"Parathyroid Carcinoma":1,
"Parathyroidectomy":1,
"Fine needle aspiration biopsy":1,
"Thyroid ultrasound":1,
"Cytokeratin-20":1,
"Merkel cell carcinoma":1,
"Thyroid Transcription Factor-1":1,
"primary cutaneous neuroendocrine carcinoma":1,
"Lymphocyte-to-monocyte ratio":1,
"three-dimensional laparoscopy":1,
"imaging examination":1,
"ESE-1":1,
"gene therapy":1,
"microbubbles":1,
"theranostics":1,
"ultrasound contrast agent":1,
"controlled ovarian stimulation":1,
"fertility agents":1,
"infertility treatment":1,
"ovulation induction":1,
"CT, computed tomography":1,
"IJV, internal jugular vein":1,
"Jugular vein":1,
"MRI, magnetic resonance imaging":1,
"PET/CT, positron emission tomography/computed tomography":1,
"Plasmacytoma":1,
"Tumoral thrombus":1,
"Child":1,
"Elasticity imaging techniques":1,
"Thyroid nodule/diagnostic imaging":1,
"Cervical":1,
"Foreign-born":1,
"Immigrant":1,
"Liver":1,
"Stomach":1,
"US-born":1,
"Cystic changes":1,
"Exophthalmia":1,
"Lacrimal gland":1,
"Solitary fibrous tumour":1,
"limited calcitonin expression":1,
"parafollicular cell tumor":1,
"Bariatric surgery":1,
"Beta cell function":1,
"Glucagon-like peptide 1":1,
"Brain":1,
"morphology":1,
"Cellulitis":1,
"papillary cystic carcinoma":1,
"circDENND4C":1,
"miR-200b":1,
"miR-200c":1,
"Anoctamin":1,
"clinical outcomes":1,
"colon carcinoma":1,
"laparoscopic surgery":1,
"open surgery":1,
"cancer-associated adipocyte":1,
"miRNAs":1,
"Acromegaly":1,
"Pituitary adenoma":1,
"Thyroid nodular disease":1,
"MZ-CRC-1":1,
"heparin-binding EGF-like growth factor":1,
"mechanism":1,
"medullary thyroid carcinomas":1,
"miR-376c-3p":1            };
            var data = [];
            for (var name in keywords) {
                data.push({
                    name: name,
                    value: Math.sqrt(keywords[name])
                })
            }
            var maskImage = new Image();
            var option = {
	             title: {
                text: '2019年5月论文keyword词云'
            },
                series: [ {
                    type: 'wordCloud',
                    sizeRange: [15, 100],
                    rotationRange: [-90, 90],
                    rotationStep: 45,
                    gridSize: 2,
                    shape: 'pentagon',
                    maskImage: maskImage,
                    drawOutOfBound: false,
                    textStyle: {
                        normal: {
                            color: function () {
                                return 'rgb(' + [
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160),
                                    Math.round(Math.random() * 160)
                                ].join(',') + ')';
                            }
                        },
                        emphasis: {
                            color: 'red'
                        }
                    },
                    data: data.sort(function (a, b) {
                        return b.value  - a.value;
                    })
                } ]
            };
            maskImage.onload = function () {
                option.series[0].maskImage
                chart.setOption(option);
            }
            maskImage.src = 'data:image/png;base64,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';
            window.onresize = function () {
                chart.resize();
            }
        </script>
    </body>
</html>
